SBFM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sunshine Biopharma Inc (SBFM) is not a strong buy for a beginner, long-term investor at this time. The stock lacks positive momentum, has weak financial performance, and no recent significant catalysts to drive growth. Given the bearish technical indicators and lack of proprietary trading signals, it is better to hold off on investing in this stock currently.
The technical indicators suggest a bearish trend. The MACD is negatively expanding below 0, RSI is neutral at 31.165, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 1.128 and resistance at 1.227.
Hedge funds are significantly increasing their buying activity, with a 11812.88% increase in the last quarter.
No recent news or significant insider trading activity. Financial performance is weak with declining net income (-26.21% YoY), EPS (-79.79% YoY), and gross margin (-4.79% YoY). Technical indicators are bearish, and the stock has a high probability of further decline in the short term.
In Q3 2025, revenue increased by 11.64% YoY to $9,417,179. However, net income dropped by 26.21% YoY to -$883,820, and EPS fell by 79.79% YoY to -0.19. Gross margin also declined to 31.62%, down 4.79% YoY.
No recent analyst ratings or price target changes available.
